JOURNAL OF HEADACHE AND PAIN

Scope & Guideline

Transforming Understanding in Headache and Pain

Introduction

Explore the comprehensive scope of JOURNAL OF HEADACHE AND PAIN through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF HEADACHE AND PAIN in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1129-2369
PublisherBMC
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 2001 to 2024
AbbreviationJ HEADACHE PAIN / J. Headache Pain
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Journal of Headache and Pain focuses on disseminating research findings that advance the understanding, diagnosis, and treatment of headache disorders. The journal aims to cover a wide range of topics related to headache, including epidemiology, pathophysiology, clinical management, and novel therapeutic strategies.
  1. Epidemiology and Burden of Headache Disorders:
    Research that evaluates the prevalence, incidence, and socioeconomic impact of various headache types, including migraine, tension-type headaches, and cluster headaches.
  2. Pathophysiology and Mechanisms of Headache:
    Studies exploring the biological, neurological, and genetic underpinnings of headache disorders, including neuroinflammation, neurotransmitter pathways, and genetic susceptibility.
  3. Clinical Management and Treatment Strategies:
    Articles discussing pharmacological and non-pharmacological treatment approaches, including the use of monoclonal antibodies, neuromodulation techniques, and lifestyle interventions in headache management.
  4. Psychosocial and Quality of Life Aspects:
    Research investigating the psychological impact of headaches on patients, including comorbid conditions, mental health, and quality of life assessments.
  5. Innovative Diagnostic and Therapeutic Approaches:
    Papers focusing on advancements in diagnostic tools, imaging techniques, and emerging therapies for headache disorders.
  6. Global Perspectives on Headache Care:
    Research that addresses the disparities in headache care across different regions, including access to treatment and cultural factors influencing management.
The Journal of Headache and Pain is witnessing an increase in research focused on innovative approaches and contemporary issues in headache management. This section outlines the trending and emerging themes that are shaping the future of headache research.
  1. CGRP Pathway and Monoclonal Antibodies:
    There is a significant surge in research related to the calcitonin gene-related peptide (CGRP) pathway, with numerous studies assessing the efficacy and safety of CGRP monoclonal antibodies in migraine prevention and treatment.
  2. Telemedicine and Digital Health Solutions:
    The impact of telemedicine on headache management has gained traction, particularly following the COVID-19 pandemic, with research exploring the effectiveness of remote consultations and digital health interventions.
  3. Neuroinflammation and its Role in Headaches:
    Emerging studies are increasingly focusing on neuroinflammation as a critical factor in the pathophysiology of headaches, leading to a better understanding of chronic headache mechanisms.
  4. Psychological Aspects and Comorbidities:
    Research is trending towards understanding the interplay between psychological factors, such as anxiety and depression, and their impact on headache disorders, emphasizing the need for holistic management.
  5. Personalized and Precision Medicine Approaches:
    An increase in studies exploring personalized treatment strategies based on genetic, phenotypic, and psychosocial profiles of headache patients is becoming evident.

Declining or Waning

As the field of headache research evolves, certain themes appear to be less prevalent in recent publications compared to earlier years. This section highlights these waning scopes that may indicate shifts in research priorities or emerging trends.
  1. Traditional Pharmacological Treatments:
    There is a noticeable decrease in studies focused solely on traditional medications like triptans and analgesics, as newer therapies such as anti-CGRP monoclonal antibodies gain prominence in research.
  2. Non-Evidence-Based Treatments:
    Research on non-evidence-based or anecdotal treatments for headache disorders is less frequently published, reflecting a shift towards evidence-based medicine and clinical trials.
  3. Unidimensional Studies:
    There is a decline in studies that focus solely on one-dimensional aspects of headache without integrating psychosocial or multidimensional health outcomes.
  4. Overreliance on Retrospective Studies:
    A reduction in the number of retrospective studies as the field increasingly values prospective, randomized controlled trials and real-world evidence.

Similar Journals

HEADACHE

Pioneering Discoveries in Headache Treatment
Publisher: WILEYISSN: 0017-8748Frequency: 10 issues/year

HEADACHE is a premier academic journal dedicated to advancing the study of headache disorders through innovative research and clinical insights. Published by WILEY, this influential journal has been serving the neurology community since its inception in 1961 and is recognized as a leader in its field, boasting an impressive Q1 ranking in both Neurology and Neurology (clinical) categories for 2023. With a robust Scopus ranking of #48 in clinical neurology and #26 in neuroscience, HEADACHE consistently publishes high-quality research that contributes to the understanding and treatment of headache disorders worldwide. Although it does not offer open access options, the journal remains accessible to a wide audience through various institutional subscriptions. It aims to provide a platform for researchers, healthcare professionals, and students to exchange ideas and develop new strategies for headache management, making it an essential resource for those dedicated to improving patient outcomes in this challenging area of healthcare.

Kidney Diseases

Elevating the standard of care in kidney disease management.
Publisher: KARGERISSN: 2296-9381Frequency: 6 issues/year

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

Journal of Hematology

Innovating Insights into Blood Disorders
Publisher: ELMER PRESS INCISSN: 1927-1212Frequency: 4 issues/year

The Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.

JOURNAL OF THE NEUROLOGICAL SCIENCES

Advancing the frontiers of neurological research.
Publisher: ELSEVIERISSN: 0022-510XFrequency: 12 issues/year

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.

EPILEPSY & BEHAVIOR

Connecting research to real-world behavioral challenges.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1525-5050Frequency: 12 issues/year

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.

Journal of Pain Research

Empowering Global Research on Pain Solutions
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7090Frequency: 1 issue/year

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.

Current Journal of Neurology

Pioneering the future of neurological research and treatment.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Pain Research & Management

Elevating Standards in Pain Medicine Through Open Access
Publisher: HINDAWI LTDISSN: 1203-6765Frequency:

Pain Research & Management, published by HINDAWI LTD, is a leading academic journal that serves as a vital resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and neurology. With an impressive impact factor and categorized in the second quartile (Q2) for both anesthesiology and neurology as of 2023, the journal features high-quality, peer-reviewed research articles that address the complexities of pain management. Established in 1996 and recognized as Open Access, this journal allows unrestricted access to groundbreaking studies, thereby facilitating knowledge dissemination and collaboration within the global scientific community. With a strong ranking—34/136 in anesthesiology and 72/192 in neurology—Pain Research & Management retains a well-deserved reputation for publishing innovative and authoritative content that significantly contributes to the advancement of pain research and clinical practice. Researchers and healthcare professionals alike will find this journal indispensable for staying abreast of the latest discoveries and best practices in pain management.

Epilepsy & Behavior Reports

Illuminating the Intersection of Neurology and Behavior
Publisher: ELSEVIER SCIENCE INCISSN: Frequency: 1 issue/year

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

NEUROMUSCULAR DISORDERS

Empowering researchers with cutting-edge discoveries.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.